Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site

被引:80
作者
Howell, Katie A. [1 ]
Qiu, Xiangguo [2 ,3 ,4 ]
Brannan, Jennifer M. [5 ]
Bryan, Christopher [6 ]
Davidson, Edgar [6 ]
Holtsberg, Frederick W. [1 ]
Wec, Anna Z. [10 ]
Shulenin, Sergey [1 ]
Biggins, Julia E. [1 ]
Douglas, Robin [1 ]
Enterlein, Sven G. [1 ]
Turner, Hannah L. [7 ]
Pallesen, Jesper [7 ]
Murin, Charles D. [7 ,8 ]
He, Shihua [2 ,3 ,4 ]
Kroeker, Andrea [2 ,3 ,4 ]
Vu, Hong [1 ]
Herbert, Andrew S. [5 ]
Fusco, Marnie L. [8 ]
Nyakatura, Elisabeth K. [11 ]
Lai, Jonathan R. [11 ]
Keck, Zhen-Yong [12 ]
Foung, Steven K. H. [12 ]
Saphire, Erica Ollmann [8 ,9 ]
Zeitlin, Larry [13 ]
Ward, Andrew B. [7 ]
Chandran, Kartik [10 ]
Doranz, Benjamin J. [6 ]
Kobinger, Gary P. [2 ,3 ,4 ]
Dye, John M. [5 ]
Aman, M. Javad [1 ]
机构
[1] Integrated BioTherapeut Inc, Gaithersburg, MD 20878 USA
[2] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB R3E 3R2, Canada
[3] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada
[4] Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 0J9, Canada
[5] US Army Med Res Inst Infect Dis, Frederick, MD 21702 USA
[6] Integral Mol, Philadelphia, PA 19104 USA
[7] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA
[8] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
[9] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[10] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[11] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA
[12] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
[13] Mapp Biopharmaceut, San Diego, CA 92121 USA
基金
美国国家科学基金会;
关键词
NIEMANN-PICK C1; MONOCLONAL-ANTIBODIES; NONHUMAN-PRIMATES; MOLECULAR CHARACTERIZATION; NEUTRALIZING ANTIBODY; FILOVIRUS ENTRY; MARBURG VIRUS; GUINEA-PIG; DISEASE; PROPHYLAXIS;
D O I
10.1016/j.celrep.2016.04.026
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Previous efforts to identify cross-neutralizing antibodies to the receptor-binding site (RBS) of ebolavirus glycoproteins have been unsuccessful, largely because the RBS is occluded on the viral surface. We report a monoclonal antibody (FVM04) that targets a uniquely exposed epitope within the RBS; cross-neutralizes Ebola (EBOV), Sudan (SUDV), and, to a lesser extent, Bundibugyo viruses; and shows protection against EBOV and SUDV in mice and guinea pigs. The antibody cocktail ZMapp (TM) is remarkably effective against EBOV (Zaire) but does not cross-neutralize other ebolaviruses. By replacing one of the ZMapp (TM) components with FVM04, we retained the anti-EBOV efficacy while extending the breadth of protection to SUDV, thereby generating a cross-protective antibody cocktail. In addition, we report several mutations at the base of the ebolavirus glycoprotein that enhance the binding of FVM04 and other cross-reactive antibodies. These findings have important implications for pan-ebolavirus vaccine development and defining broadly protective antibody cocktails.
引用
收藏
页码:1514 / 1526
页数:13
相关论文
共 52 条
[51]   A Forward Genetic Strategy Reveals Destabilizing Mutations in the Ebolavirus Glycoprotein That Alter Its Protease Dependence during Cell Entry [J].
Wong, Anthony C. ;
Sandesara, Rohini G. ;
Mulherkar, Nirupama ;
Whelan, Sean P. ;
Chandran, Kartik .
JOURNAL OF VIROLOGY, 2010, 84 (01) :163-175
[52]   Development and Characterization of a Guinea Pig-Adapted Sudan Virus [J].
Wong, Gary ;
He, Shihua ;
Wei, Haiyan ;
Kroeker, Andrea ;
Audet, Jonathan ;
Leung, Anders ;
Cutts, Todd ;
Graham, Jill ;
Kobasa, Darwyn ;
Embury-Hyatt, Carissa ;
Kobinger, Gary P. ;
Qiu, Xiangguo .
JOURNAL OF VIROLOGY, 2016, 90 (01) :392-399